Table 1.
Baseline demographic data of group A (current topical therapy + PEA 600 mg one tablet a day, in the first period) and group B (current topical therapy alone, in the first period).
| Overall group (40 patients) | Group A (21 patients) | Group B (19 patients) | |
|---|---|---|---|
| Age (median [IQR] years) | 66.7 [61.5–73.5] | 67.6 [62.3–75.5] | 66.7 [55.7–70] |
| Gender (number, %) | |||
| Male | 21 (52.5) | 10 (47.6) | 11 (57.9) |
| Female | 19 (47.5) | 11 (52.4) | 8 (42.1) |
| Diagnosis | |||
| POAG (N, %) | 35 (87.5) | 18 (85.7) | 17 (89.5) |
| NTG (N, %) | 5 (12.5) | 3 (14.3) | 2 (10.5) |
| Concomitant systemic diseases (N, %) | |||
| Systemic hypertension | 11 (27.5) | 7 (33.3) | 4 (21.1) |
| Hypercholesterolaemia | 7 (17.5) | 2 (9.5) | 5 (26.3) |
| Vascular disorders | 6 (15) | 3 (14.3) | 3 (15.8) |
| Diabetes | 5 (12.5) | 3 (14.3) | 2 (10.5) |